Observational studyBMC neurology2022
Long-term outcomes of edaravone in amyotrophic lateral sclerosis in South Korea: 72-week observational study.
Jin-Mo Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it